Owen Mumford Malaysia Signs MOU with Diabetes Malaysia to Expand Access to Life-Saving Diabetes Management Devices

January 25

On January 12, 2025, Owen Mumford Malaysia signed a Memorandum of Understanding (MOU) with Diabetes Malaysia, aiming to enhance access to essential diabetes management devices for underprivileged groups. The signing ceremony was attended by Dr. Mohazmi bin Mohammad, General Secretary of Diabetes Malaysia, along with committee members, Owen Mumford’s business partner Duopharma Marketing, representatives from Medicskill, an education provider and 15 active and curious children and their caregivers, who are members of the Diabetes Malaysia.


As a global business and employer, we are deeply committed to balancing our responsibilities toward people and the planet with our business goals. This commitment is reflected in our proud status as a B-Corp certified organization since 2021.


Owen Mumford Malaysia, established in 2015, has consistently aimed to elevate healthcare by understanding and addressing the needs of healthcare professionals and patients. Through our partnership with Duopharma Marketing, we have expanded our reach to individuals living with diabetes by supplying our products through retail pharmacies and starter kits from the Ministry of Health Malaysia (KKM), facilitating easier access to pen needles and lancets for daily diabetes management.


This MOU represents our commitment to giving back to the community. Our collaboration with Diabetes Malaysia will support their outreach programs for patients in need. We pledge to donate pen needles and lancets and assist in their various awareness initiatives.


By joining forces, we strengthen our efforts to increase access to essential diabetes management solutions, ensuring that those who need them can improve their quality of life.